Creating a blood test for herpes simplex viruses 1 and 2.
SBIR Topic 133: Development of a Serological Test for Herpes Simplex Types 1 and 2 Infections
This study is working on a new blood test that can help find out if someone has been infected with the herpes virus, so that people can get better treatment and support for their condition.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Kephera Diagnostics, LLC NIH-funded |
| Lab location | 1 site (Framingham, UNITED STATES) |
| Project ID | NIH-11203290 on NIH RePORTER |
What this research studies
This research focuses on developing a serological test that can accurately detect infections caused by Herpes Simplex Virus types 1 and 2. The approach involves creating a diagnostic tool that can identify antibodies in the blood, which indicates whether a person has been infected with these viruses. By improving the accuracy and availability of testing, this research aims to enhance the diagnosis and management of herpes infections, ultimately benefiting patients through better-informed treatment options.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals who suspect they may have been infected with herpes simplex viruses 1 or 2.
Not a fit: Patients who have already been diagnosed and are receiving effective treatment for herpes simplex infections may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could provide a reliable and accessible blood test for diagnosing herpes simplex infections, leading to improved patient care.
How similar studies have performed: Other research has shown success in developing serological tests for viral infections, indicating that this approach has potential for success.
Where this research is happening
Framingham, UNITED STATES
- Kephera Diagnostics, LLC — Framingham, United States (Active)
Researchers
- Principal investigator: Levin, Andrew — Kephera Diagnostics, LLC
- Study coordinator: Levin, Andrew
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.